UK markets closed

Mochida Pharmaceutical Co., Ltd. (MFY.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
17.00-0.30 (-1.73%)
As of 08:25AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
102,885,000
-
103,261,000
110,179,000
102,995,000
101,801,000
Cost of revenue
50,815,000
-
48,146,000
50,626,000
48,203,000
49,882,000
Gross profit
52,070,000
-
55,114,000
59,553,000
54,791,000
51,919,000
Operating expenses
Selling general and administrative
46,267,000
-
46,607,000
45,161,000
42,788,000
43,112,000
Total operating expenses
46,267,000
-
46,607,000
45,161,000
42,788,000
43,112,000
Operating income or loss
5,803,000
-
8,507,000
14,392,000
12,003,000
8,807,000
Interest expense
2,000
-
0
0
-
-
Income before tax
6,160,000
-
9,044,000
14,591,000
11,900,000
6,273,000
Income tax expense
1,613,000
-
2,395,000
4,022,000
3,312,000
1,675,000
Income from continuing operations
4,547,000
-
6,649,000
10,569,000
8,588,000
4,598,000
Net income
4,547,000
-
6,649,000
10,569,000
8,587,000
4,598,000
Net income available to common shareholders
4,547,000
-
6,649,000
10,569,000
8,587,000
4,598,000
Basic EPS
152.70
126.80
178.93
277.39
222.29
-
Diluted EPS
152.70
126.80
178.93
277.39
222.29
-
Basic average shares
36,516
35,860
37,160
38,102
38,633
-
Diluted average shares
36,516
35,860
37,160
38,102
38,633
-